n-(2,6-dimethylergoline-8-yl)-2,2-dimethylpropanamide has been researched along with hydrazine in 1 studies
| Studies (n-(2,6-dimethylergoline-8-yl)-2,2-dimethylpropanamide) | Trials (n-(2,6-dimethylergoline-8-yl)-2,2-dimethylpropanamide) | Recent Studies (post-2010) (n-(2,6-dimethylergoline-8-yl)-2,2-dimethylpropanamide) | Studies (hydrazine) | Trials (hydrazine) | Recent Studies (post-2010) (hydrazine) |
|---|---|---|---|---|---|
| 14 | 0 | 0 | 12,034 | 330 | 3,193 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baldessarini, RJ; Huston-Lyons, D; Marsh, ER | 1 |
1 other study(ies) available for n-(2,6-dimethylergoline-8-yl)-2,2-dimethylpropanamide and hydrazine
| Article | Year |
|---|---|
Effects of dopamine partial-agonist aminoergolines on dopamine metabolism in limbic and extrapyramidal regions of rat brain.
Topics: 4-Butyrolactone; Animals; Dihydroxyphenylalanine; Dopamine; Dopamine Agents; Dose-Response Relationship, Drug; Ergolines; Extrapyramidal Tracts; Hydrazines; Limbic System; Male; Rats; Rats, Sprague-Dawley | 1994 |